July 11, 2024

CATAWBA RESEARCH WELCOMES TRACY HUDSON AS NEW HEAD OF PROPOSALS

CHARLOTTE, N.C.; July 11, 2024 – Catawba Research, dedicated to becoming the world’s most trusted Contract Research Organization (CRO), is thrilled to announce the addition of Tracy Hudson as its new Vice President of Proposals and Vendor Management. With a remarkable career spanning over 30 years, Tracy brings unparalleled expertise and a proven record of driving strategic business results.

Throughout her career, she has supported global outsourcing strategy across all phases of research at innovator companies such as Sunovion Pharmaceuticals, Schering-Plough and Aventis Pharmaceuticals. In her most recent role as Vice President at Syneos Health, Tracy supported the transformation of strategic business development support for top 50 customers, and led a complex global team that supported sales targets exceeding $5 billion and accelerated the growth of new proposal requests.

“Tracy’s extensive expertise and innovative approach are invaluable assets to our team,” said Andy Silverman , CEO of Catawba Research. “Her proven leadership and strategic vision align perfectly with our mission to deliver top-tier CRO capabilities with exceptional customer service. I’m excited to welcome her aboard and look forward to the incredible impact she will make.”

With a commitment to mentoring and developing talent, Tracy exemplifies the values of respect, integrity and innovation. Her addition to Catawba Research leadership team underscores our dedication to attracting top talent and driving excellence in the CRO industry.

About Catawba Research
Catawba Research is a full-service contract research organization (CRO) providing clinical management expertise and services. Our executive leadership team has over 160 years of experience and is comprised of industry professionals from large global pharmaceutical, small- and medium-sized biotechnology, global full-service CRO, and eClinical technology backgrounds. Our cross functional team of clinical trial professionals have successfully supported 800+ clinical trials across their careers and since 2014, our work has delivered 33 regulatory agency approvals. As an international service provider, we have headquarters in North Carolina, USA and Mumbai, India. Our service offering also includes a Site Management Organization (SMO) based in Texas, USA. For more information, please visit www.catawbaresearch.com.

Won’t you get hip to this kindly tip, get your kicks on Route 505(b)(2). What is that?Route 505(b)(2) vs. 505(j)Altasciences Acquires WCCT Global“ This acquisition is an integral part of Altasciences’ strategic growth plan to provide a comprehensive, fully integrated early phase drug development solution to address the ever-changing outsourcing challenges of biopAn Overview of GDUFAThe Office of Generic Drugs (OGD) reports directly to the Director of the Center for Drug Evaluation and Research (CDER). The OGD’s mission is to ensure safe, effective, and affordable medicines for the American public.Catawba Research Concludes Another Rosacea Clinical TrialCatawba Research is pleased to announce another achievement for a recently completed rosacea clinical trial. In this trial, Catawba enrolled more than 1000 rosacea subjects in 22 weeks from 33 sites .Catawba Research Achieves Acne First-to-FileThe team at Catawba Research has recently completed a first-to-file submission for acne clinical trial . In this study, Catawba enrolled a staggering 1125 acne vulgaris subjects in 8 weeks from 12 sites .Catawba Research Adds Tinea Pedis Video to Training LibraryTo learn more about our training program or see some our videos, contact us !